1. Foreword

   • Federico Cappuzzo

   EditorialNotes 29 December 2012 Pages: 1 - 2

2. Clinical Outcomes with Erlotinib in Patients with Epidermal Growth Factor Receptor Mutation

   • Tony S. K. Mok
   • Manolo D’arcangelo
   • Raffaele Califano

   Review Article 29 December 2012 Pages: 3 - 10

3. Role of Erlotinib in the Treatment of Non-Small Cell Lung Cancer

   • Bilal Piperdi
   • Roman Perez-Soler

   Review Article 29 December 2012 Pages: 11 - 19

4. Management of Non-Small Cell Lung in Cancer Patients with Stable Disease

   • Francesco Grossi

   Review Article 29 December 2012 Pages: 20 - 27

5. Prognostic and Predictive Value of K-RAS Mutations in Non-Small Cell Lung Cancer

   • Raffaele Califano
   • Lorenza Landi
   • Federico Cappuzzo

   Review Article 29 December 2012 Pages: 28 - 36

6. Emerging New Agents for the Management of Patients with Non-Small Cell Lung Cancer

   • Enrica Capelletto
   • Silvia Novello

   Review Article 29 December 2012 Pages: 37 - 52